Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation

NCT03545919 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-08-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical significance of community-acquired respiratory virus (CARV) infection in patients with lung transplantation;Explore the lung microbiome dynamics within one year after lung transplantation;Find the relationship between lung microbiome and chronic lung allograft dysfunction(CLAD).

Conditions

  • Lung Transplant Infection
  • Lung Transplant Rejection

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    collaborator OTHER
  • Chinese Academy of Medical Sciences

    collaborator OTHER
  • Capital Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-05
Primary Completion
2022-06-01
Completion
2022-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545919 on ClinicalTrials.gov